Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. AmniSure versus fern testing to assess the rupture of fetal membranes in pregnant women: a review of the comparative accuracy, cost-effectiveness, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2012 Authors' conclusions Evidence suggests that AmniSure is an accurate method for detecting rupture of fetal membranes, but studies examining performance compared with fern testing are limited in number. No cost-effectiveness evidence or evidence-based guidelines were identified. Indexing Status Subject indexing assigned by CRD MeSH Amniotic Fluid; Diagnostic Techniques, Obstetrical and Gynecological; Females; Fetal Membranes, Premature Rupture; Predictive Value of Tests; Pregnancy Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, K1S 5S8 Ottawa, Ontario Canada Email: htainfo@cadth.ca AccessionNumber 32012000670 Date abstract record published 11/10/2012 |